Cerro de Pasco Resources Ongoing Assay Results at Quiulacocha Indicate Consistency at Depth and Laterally
December 03, 2024 07:00 ET
|
Cerro de Pasco Resources
Assay Results at Quiulacocha: 177 assay samples from nine drill holes, indicate an average silver grade of 1.72 ounces per tonne (oz/t).
G-III Apparel Group Announces Date for Third Quarter 2025 Results
December 03, 2024 07:00 ET
|
G-III Apparel Group, LTD.
G-III Apparel Group, Ltd., today announced that it will release its third quarter 2025 earnings before the market opens on Tuesday, December 10, 2024.
Coherus Announces Agreement to Divest UDENYCA® Franchise for up to $558 million to Intas Pharmaceuticals Ltd.
December 03, 2024 07:00 ET
|
Coherus BioSciences, Inc.
- Coherus to focus exclusively on innovative immuno-oncology programs that include LOQTORZI®, an FDA approved, next-generation programmed cell death protein 1 (PD-1) inhibitor - - Proceeds to fund...
Keros Therapeutics Announces Global License Agreement with Takeda to Advance Elritercept
December 03, 2024 07:00 ET
|
Keros Therapeutics, Inc.
Keros Therapeutics to receive upfront payment of $200 million and is eligible to receive development, approval and commercial milestone payments with the potential to exceed $1.1 billion and tiered...
Ero Copper Announces Updated Mineral Reserve and Resource Estimates for the Xavantina Operations
December 03, 2024 07:00 ET
|
Ero Copper Corp.
VANCOUVER, British Columbia, Dec. 03, 2024 (GLOBE NEWSWIRE) -- Ero Copper Corp. (TSX: ERO, NYSE: ERO) ("Ero" or the “Company”) is pleased to announce an update of its National Instrument 43-101 (“NI...
Online Trading Platform Market to Witness 14.74% CAGR by 2031 | SkyQuest Technology
December 03, 2024 07:00 ET
|
SkyQuest Technology Consulting Pvt. Ltd.
Westford, USA, Dec. 03, 2024 (GLOBE NEWSWIRE) -- SkyQuest projects that Online Trading Platform Market size will attain the value of USD 14.04 Billion by 2031, with a CAGR of 14.74% during the...
Kinevant Sciences Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis
December 03, 2024 07:00 ET
|
Roivant Sciences
Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosisFurther development of namilumab for the treatment of sarcoidosis will be discontinued BASEL, Switzerland and...
Terns Pharmaceuticals Announces Positive Early Data from Phase 1 CARDINAL Trial of TERN-701 for Chronic Myeloid Leukemia
December 03, 2024 07:00 ET
|
Terns Pharmaceuticals, Inc.
Compelling molecular responses starting at lowest dose level in heavily pre-treated patients with high baseline BCR-ABL transcript levels Encouraging safety profile with no dose limiting toxicities,...
Roivant Announces Topline Results from Phase 2 RESOLVE-Lung Study of Namilumab in Chronic Active Pulmonary Sarcoidosis
December 03, 2024 07:00 ET
|
Roivant Sciences
Namilumab failed to show treatment benefit in patients with pulmonary sarcoidosisFurther development of namilumab for the treatment of sarcoidosis will be discontinued BASEL, Switzerland and LONDON...
Rehmann Foundation Grants $100,000 to Support Local Organizations
December 03, 2024 07:00 ET
|
Rehmann
TROY, Mich., Dec. 03, 2024 (GLOBE NEWSWIRE) -- The nonprofit Rehmann Foundation today announced that it has awarded $100,000 in grants to nine outstanding organizations in Michigan, Ohio, and...
- December 20, 2024 03:07 ET Jiaoxi Ancient Town Protection and Utilization Project (Phase II) Has the Latest Progress, and Jiaoxi Streets and Alleys are Lively and Prosperous Again
- December 20, 2024 03:02 ET DuckChain Announces $5 Million Funding from Dao5, Tandem by Offchain Labs, and Others, Launches Yellow Duck Mission Global Hackathon